Stay updated on Delgocitinib Cream Dose-ranging Clinical Trial
Sign up to get notified when there's something new on the Delgocitinib Cream Dose-ranging Clinical Trial page.

Latest updates to the Delgocitinib Cream Dose-ranging Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe page now displays Revision: v3.4.2. The government funding lapse notice banner was removed.SummaryDifference0.3%

- Check15 days agoChange DetectedA government funding/status notice was added, informing users about potential operational updates; the page version was updated from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check22 days agoChange DetectedThe page adds a Show glossary option and updates QC criteria labeling, FEAR Act data wording, and the revision/version from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check36 days agoChange DetectedPage revision label updated from v3.3.3 to v3.3.4. This appears to be a minor version update with no changes to study content or results.SummaryDifference0.0%

- Check57 days agoChange DetectedLocations section updated with new site locations across the US, Canada, and Australia and older location entries removed under a newer revision. This reflects changes in where the trial is conducted and where participants may enroll.SummaryDifference1%

- Check86 days agoChange DetectedRevision: v3.3.2 updated on the page (replacing v3.2.0).SummaryDifference0.0%

Stay in the know with updates to Delgocitinib Cream Dose-ranging Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Delgocitinib Cream Dose-ranging Clinical Trial page.